Skip to main content
. Author manuscript; available in PMC: 2016 Aug 13.
Published in final edited form as: Birth Defects Res A Clin Mol Teratol. 2016 May 11;106(8):685–695. doi: 10.1002/bdra.23517

TABLE 5.

Odds Ratio (OR) and 95% Confidence Interval (CI) for Maternal Plasma Folate Receptor (FR) Autoantibodies Immunoglobulin G (IgG) and IgM Levels in Relation to Neural Tube Defects (NTDs), Stratified by Gestational Age, China, 2011–2013 (N = 327a)

Autoantibody Gestational age ≤20 weeks Gestational age >20 weeks
Controls
n
NTDs Controls
n
NTDs
n OR (95% CI) aOR (95% CI)b n OR (95% CI) aOR (95% CI)b
IgG
 Tertile 1 (<0.39) 1           2 Reference Reference 70           7 Reference Reference
 Tertile 2 (0.39–1.07) 1           3 1.50 (0.06–40.63) 2.70 (0.08–95.00) 71         22 3.10 (1.24–7.72) 3.25 (1.21–8.71)
 Tertile 3 (> 1.07) 4         12 1.50 (0.11–21.31) 2.01 (0.10–39.90) 67         57 8.51 (3.62–19.97) 8.47 (3.36–21.33)
P for trend 0.794 0.751 <0.001 <0.001
IgM
 Tertile 1 (<1.47) 2           1 Reference Reference 68         14 Reference Reference
 Tertile 2 (1.47–2.79) 2           4 4.00 (0.21–75.66) 8.78 (0.16–488.63) 70         16 1.11 (0.50–2.45) 1.09 (0.47–2.53)
 Tertile 3 (>2.79) 2         12 12.00 (0.71–203.13) 18.98 (0.51–699.56) 70         56 3.89 (1.98–7.62) 4.50 (2.17–9.31)
P for trend 0.078 0.109 <0.001 <0.001
a

Twenty-three participants were excluded due to failure to obtain the maternal blood sample.

b

Adjusted for age, parity, periconceptual folate supplementation, and gestational age.

aOR, adjusted odds ratio.